529 related articles for article (PubMed ID: 27818276)
21. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.
Zeng Y; Luo M; Pan L; Chen Y; Guo S; Luo D; Zhu L; Liu Y; Pan L; Xu S; Zhang R; Zhang C; Wu P; Ge L; Noureddin M; Pandol SJ; Han YP
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G542-G553. PubMed ID: 31984787
[TBL] [Abstract][Full Text] [Related]
23. Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.
Zhang YG; Xia Y; Zhang J; Deb S; Garrett S; Sun J
Gut Microbes; 2023; 15(1):2202593. PubMed ID: 37074210
[TBL] [Abstract][Full Text] [Related]
24. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D and Cystic Fibrosis Lung Disease.
Loukou I; Boutopoulou B; Fouzas S; Douros K
Mini Rev Med Chem; 2015; 15(12):974-83. PubMed ID: 26242701
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation.
Fakhoury HMA; Kvietys PR; AlKattan W; Anouti FA; Elahi MA; Karras SN; Grant WB
J Steroid Biochem Mol Biol; 2020 Jun; 200():105663. PubMed ID: 32194242
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
28. Development of the intestinal microbiome in cystic fibrosis in early life.
Price CE; Hampton TH; Valls RA; Barrack KE; O'Toole GA; Madan JC; Coker MO
mSphere; 2023 Aug; 8(4):e0004623. PubMed ID: 37404016
[TBL] [Abstract][Full Text] [Related]
29. Gut-liver axis signaling in portal hypertension.
Simbrunner B; Mandorfer M; Trauner M; Reiberger T
World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis.
Zhu T; Liu TJ; Shi YY; Zhao Q
Int J Mol Med; 2015 May; 35(5):1213-8. PubMed ID: 25813397
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals.
Luthold RV; Fernandes GR; Franco-de-Moraes AC; Folchetti LG; Ferreira SR
Metabolism; 2017 Apr; 69():76-86. PubMed ID: 28285654
[TBL] [Abstract][Full Text] [Related]
32. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis.
Brandl C; Bucci L; Schett G; Zaiss MM
Eur J Immunol; 2021 Apr; 51(4):798-810. PubMed ID: 33594693
[TBL] [Abstract][Full Text] [Related]
33. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
34. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
35. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D deficiency and the pathogenesis of Crohn's disease.
White JH
J Steroid Biochem Mol Biol; 2018 Jan; 175():23-28. PubMed ID: 28025175
[TBL] [Abstract][Full Text] [Related]
37. The role of UVR and vitamin D on T cells and inflammatory bowel disease.
Bora S; Cantorna MT
Photochem Photobiol Sci; 2017 Mar; 16(3):347-353. PubMed ID: 27714313
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.
Welcome MO
Neuromolecular Med; 2019 Sep; 21(3):205-226. PubMed ID: 31115795
[TBL] [Abstract][Full Text] [Related]
39. Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency.
Golan MA; Liu W; Shi Y; Chen L; Wang J; Liu T; Li YC
Dig Dis Sci; 2015 Jul; 60(7):1941-7. PubMed ID: 25894930
[TBL] [Abstract][Full Text] [Related]
40. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
